**Core Concept**
The question is testing knowledge of **hormone receptor-positive breast cancer** treatment. **Tamoxifen** is a well-known drug in this context, acting as a **selective estrogen receptor modulator (SERM)**.

**Why the Correct Answer is Right**
Tamoxifen binds to **estrogen receptors** on breast cancer cells, blocking the action of **estrogen** and inhibiting cancer cell growth. This mechanism is crucial in treating **hormone receptor-positive breast cancer**. By occupying the **estrogen receptor**, tamoxifen prevents **estrogen** from promoting cancer cell proliferation.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect as it is not specified.
**Option B:** Incorrect as it is not provided.
**Option C:** Incorrect as the option is missing.
**Option D:** Incorrect as the option is not given.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **tamoxifen** can have **partial estrogen agonist effects** on other tissues, such as the **endometrium**, which can lead to **endometrial cancer** as a side effect.

**Correct Answer:** D. Tamoxifen